Early research (Phase 1)Ended earlyNCT00022971
What this trial is testing
Combination Antibody Therapy for Relapsed Lymphoma and Chronic Lymphocytic Leukemia
Who this might be right for
Diffuse Large B-Cell LymphomaFollicular LymphomaChronic Lymphocytic Leukemia+2 more
National Cancer Institute (NCI) 35